Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
27 March 2018 Photo Earl Coetzee
Research focus on HIV and TB stigma among healthcare workers
Posters reading, “Let’s Stop Stigma” urge healthcare workers to ”Be kind to yourself. Be kind to others.” Pictured here are Dr Asta Rau, Director of CHSR&D and Dr Michelle Engelbrecht, deputy director of the centre.

Researchers working on an internationally funded project are tackling a key occupational health issue: HIV and TB stigma among Free State healthcare workers. They developed and rolled out interventions to decrease stigma and will soon measure the effects. 
In this four-year project, UFS researchers from the Centre for Health Systems Research and Development (CHSR&D) are partnering with Antwerp University and the Free State Department of Health.  

Stigma is like an invisible mark 
A project leader at the CHSR&D, Dr Asta Rau, says most research on stigma in public health focuses on HIV stigma towards patients. Little is done on stigma among healthcare workers themselves. 
Dr Rau says that stigma undermines people’s dignity and causes them suffering. It can even stop them from seeking healthcare. Stigma threatens the health of healthcare workers and the stability of the health system, which is already under strain due to personnel shortages. 

Interventions to make a difference

The research identified two types of stigma - external stigma that can be seen around us, e.g. in the way healthcare workers speak about or treat one another and internal stigma that happens when healthcare workers take this ‘outside’ stigma and turn it inward on themselves. 

Dr Rau says the interventions involve training healthcare workers about what stigma is and how to go about reducing it. “We give them the knowledge and tips on how to communicate when they encounter stigma. It is up to them to then use that to fight stigma.” A communication campaign with posters and branded social marketing materials supports the training. The campaign uses a single slogan: ”Let’s Stop Stigma” and urges healthcare workers to ”Be kind to yourself. Be kind to others."

News Archive

New research informs improved treatment of brain inflammation
2017-10-13

Description: Sebolai and Ogundeji Tags: Microbiologist, Dr Adepemi Ogundeji,  

Dr Adepemi Ogundeji, researcher in the Department of Microbial,
Biochemical and Food Biotechnology at the
University of the Free State,
and Dr Olihile Sebolai,
her study leader from the same department.
Photo: Charl Devenish



Microbiologist Dr Adepemi Ogundeji has uncovered a new use for an old medicine that can potentially save lives and money. Under the guidance of her study leader, Dr Olihile Sebolai, Dr Ogundeji set out to fight a fungal disease caused by Cryptococcus neoformans. Drs Ogundeji and Sebolai are from the University of the Free State Department of Microbial, Biochemical and Food Biotechnology. 

Dr Ogundeji is passionate about education. “My aim will always be to transfer knowledge and skills in the microbiology field,” she said. “Dr Ogundeji’s study is celebrated in that it found a new purpose for existing medicines. An advantage of repositioning old medicines is by-passing clinical trials, which sometimes take 20 years, and the safety of such medicines is already known,” Dr Sebolai, explained.

Cryptococcus infections are difficult to control and often lead to brain inflammation. In layman’s terms: “Your brain is on fire”. People with HIV/Aids are especially vulnerable, surviving only about three months without treatment. Such patients may present with a Cryptococcus-emergent psychosis, and some with an out-of-control inflammatory condition when initiated on ARVs. 

Dr Ogundeji found that the clinically recommended dosage of aspirin (anti-inflammatory medicine), and quetiapine (anti-psychotic medicine) is sufficient to control the infection. Her exceptional work was readily published in some of the foremost journals in her field, namely, Antimicrobial Agents and Chemotherapy and Frontiers in Microbiology

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept